Diagnostic efficacy of magnifying endoscopy with blue laser imaging for laryngopharyngeal reflux.

IF 3.1 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL
Frontiers in Medicine Pub Date : 2025-09-24 eCollection Date: 2025-01-01 DOI:10.3389/fmed.2025.1642702
Rong Wang, Min Yu, Chaoyuan Chen, Xi Chen, Yongxiu Lin, Jianzhen Li, Gang Liu, Huan Huang, Dazhou Li, Wen Wang
{"title":"Diagnostic efficacy of magnifying endoscopy with blue laser imaging for laryngopharyngeal reflux.","authors":"Rong Wang, Min Yu, Chaoyuan Chen, Xi Chen, Yongxiu Lin, Jianzhen Li, Gang Liu, Huan Huang, Dazhou Li, Wen Wang","doi":"10.3389/fmed.2025.1642702","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>We aimed to analyze the utility of magnifying endoscopy with blue laser imaging (ME-BLI) in diagnosing laryngopharyngeal reflux (LPR).</p><p><strong>Methods: </strong>The study enrolled 106 patients based on LPR-related symptoms. Using the reflux symptom index (RSI) and reflux finding score (RFS) scales as the clinical reference standard, the study cohort comprised 68 patients with LPR (RSI >13 and/or RFS >7) and 38 controls (RSI ≤13 and RFS ≤7). All participants underwent upper gastrointestinal endoscopy with ME-BLI. The patients were classified into Grades 1-4 based on the pharyngolaryngeal appearance under ME-BLI and the visibility and characteristics of intraepithelial papillary capillary loops (IPCLs) in the pharyngolaryngeal mucosa. Grades 3 and 4 were defined as LPR-positive. The diagnostic performance of ME-BLI for LPR was compared to the RSI/RFS criteria.</p><p><strong>Results: </strong>Compared with the RSI/RFS clinical reference standard, ME-BLI demonstrated a sensitivity of 89.71% (95% CI: 81.54-94.44%), a specificity of 73.68% (95% CI: 59.72-84.03%), a positive predictive value of 85.92% (95% CI: 76.34-92.04%), and a negative predictive value of 80.00% (95% CI: 64.06-90.04%) for LPR diagnosis. It also showed good consistency with RSI/RFS diagnosis (Kappa = 0.65, 95% CI: 0.52-0.78, <i>p</i> < 0.001). Good interobserver agreement in ME-BLI grading was noted (ICC = 0.858, <i>p</i> < 0.001).</p><p><strong>Conclusion: </strong>LPR has characteristic pharyngeal manifestations. ME-BLI could potentially improve LPR diagnostic accuracy; however, further validation is required.</p>","PeriodicalId":12488,"journal":{"name":"Frontiers in Medicine","volume":"12 ","pages":"1642702"},"PeriodicalIF":3.1000,"publicationDate":"2025-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12504507/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fmed.2025.1642702","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: We aimed to analyze the utility of magnifying endoscopy with blue laser imaging (ME-BLI) in diagnosing laryngopharyngeal reflux (LPR).

Methods: The study enrolled 106 patients based on LPR-related symptoms. Using the reflux symptom index (RSI) and reflux finding score (RFS) scales as the clinical reference standard, the study cohort comprised 68 patients with LPR (RSI >13 and/or RFS >7) and 38 controls (RSI ≤13 and RFS ≤7). All participants underwent upper gastrointestinal endoscopy with ME-BLI. The patients were classified into Grades 1-4 based on the pharyngolaryngeal appearance under ME-BLI and the visibility and characteristics of intraepithelial papillary capillary loops (IPCLs) in the pharyngolaryngeal mucosa. Grades 3 and 4 were defined as LPR-positive. The diagnostic performance of ME-BLI for LPR was compared to the RSI/RFS criteria.

Results: Compared with the RSI/RFS clinical reference standard, ME-BLI demonstrated a sensitivity of 89.71% (95% CI: 81.54-94.44%), a specificity of 73.68% (95% CI: 59.72-84.03%), a positive predictive value of 85.92% (95% CI: 76.34-92.04%), and a negative predictive value of 80.00% (95% CI: 64.06-90.04%) for LPR diagnosis. It also showed good consistency with RSI/RFS diagnosis (Kappa = 0.65, 95% CI: 0.52-0.78, p < 0.001). Good interobserver agreement in ME-BLI grading was noted (ICC = 0.858, p < 0.001).

Conclusion: LPR has characteristic pharyngeal manifestations. ME-BLI could potentially improve LPR diagnostic accuracy; however, further validation is required.

蓝色激光放大内镜对咽喉反流的诊断价值。
目的:分析放大内镜蓝激光成像(ME-BLI)在诊断喉咽反流(LPR)中的应用价值。方法:根据lpr相关症状入组106例患者。以反流症状指数(RSI)和反流发现评分(RFS)量表作为临床参考标准,研究队列包括68例LPR患者(RSI >13和/或RFS >7)和38例对照组(RSI≤13和RFS≤7)。所有参与者都接受了ME-BLI上消化道内窥镜检查。根据ME-BLI下咽部外观及咽粘膜上皮内乳头状毛细血管袢(IPCLs)的可见性和特征,将患者分为1-4级。3级和4级为lpr阳性。将ME-BLI对LPR的诊断性能与RSI/RFS标准进行比较。结果:与RSI/RFS临床参考标准相比,ME-BLI诊断LPR的敏感性为89.71% (95% CI: 81.54 ~ 94.44%),特异性为73.68% (95% CI: 59.72 ~ 84.03%),阳性预测值为85.92% (95% CI: 76.34 ~ 92.04%),阴性预测值为80.00% (95% CI: 64.06 ~ 90.04%)。与RSI/RFS诊断也有较好的一致性(Kappa = 0.65,95% CI: 0.52 ~ 0.78, p p )结论:LPR具有特征性的咽部表现。ME-BLI有可能提高LPR诊断的准确性;然而,需要进一步的验证。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Frontiers in Medicine
Frontiers in Medicine Medicine-General Medicine
CiteScore
5.10
自引率
5.10%
发文量
3710
审稿时长
12 weeks
期刊介绍: Frontiers in Medicine publishes rigorously peer-reviewed research linking basic research to clinical practice and patient care, as well as translating scientific advances into new therapies and diagnostic tools. Led by an outstanding Editorial Board of international experts, this multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide. In addition to papers that provide a link between basic research and clinical practice, a particular emphasis is given to studies that are directly relevant to patient care. In this spirit, the journal publishes the latest research results and medical knowledge that facilitate the translation of scientific advances into new therapies or diagnostic tools. The full listing of the Specialty Sections represented by Frontiers in Medicine is as listed below. As well as the established medical disciplines, Frontiers in Medicine is launching new sections that together will facilitate - the use of patient-reported outcomes under real world conditions - the exploitation of big data and the use of novel information and communication tools in the assessment of new medicines - the scientific bases for guidelines and decisions from regulatory authorities - access to medicinal products and medical devices worldwide - addressing the grand health challenges around the world
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信